A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins

Cancer Research

Volumn 71, Issue 9, 2011, Pages 3296-3305

  Destouches, Damien ^a,b   Page, Nicolas ^c   Hamma Kourbali, Yamina ^a   Machi, Valérie ^c   Chaloin, Olivier ^c   Frechault, Sophie ^a   Birmpas, Charalampos ^f   Katsoris, Panagiotis ^f   Beyrath, Julien ^c   Albanese, Patricia ^a   Maurer, Marie ^e   Carpentier, Gilles ^a   Strub, Jean Marc ^d   Van Dorsselaer, Alain ^d   Muller, Sylviane ^c   Bagnard, Dominique ^d   Briand, Jean Paul ^c   Courty, José ^a  

^a Université Paris Est Créteil   (France)

^b ImmuPharma   (France)

^c INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^f UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; LIPOCORTIN 5; MULTIVALENT PSEUDOPEPTIDE; N6L; NUCLEOLIN; NUCLEOPHOSMIN; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL SURFACE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG DISTRIBUTION; DRUG TARGETING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

EID: 79955503446     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-3459     Document Type: Article

References (37)

1. Christian S, Pilch J, Akerman ME, Porkka K, Laakkonen P, Ruoslahti E. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J Cell Biol 2003;163:871-8. (Pubitemid 37517893)
2. Ginisty H, Sicard H, Roger B, Bouvet P. Structure and functions of nucleolin. J Cell Sci 1999;112:761-72. (Pubitemid 29179310)
3. Hovanessian AG, Puvion-Dutilleul F, Nisole S, Svab J, Perret E, Deng JS, et al. The cell-surface-expressed nucleolin is associated with the actin cytoskeleton. Exp Cell Res 2000;261:312-28. (Pubitemid 32010228)
4. Srivastava M, Pollard HB. Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J 1999;13:1911-22. (Pubitemid 29517621)
5. Di Segni A, Farin K, Pinkas-Kramarski R. Identification of nucleolin as new ErbB receptors- interacting protein. PLoS One 2008;3:e2310.
6. Said EA, Courty J, Svab J, Delbe J, Krust B, Hovanessian AG. Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin. FEBS J 2005;272:4646-59. (Pubitemid 41366988)
7. Said EA, Krust B, Nisole S, Svab J, Briand JP, Hovanessian AG. The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor. J Biol Chem 2002;277:37492-502.
8. Tate A, Isotani S, Bradley MJ, Sikes RA, Davis R, Chung LW, et al. Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells. BMC Cancer 2006;6:197.
9. Dumler I, Stepanova V, Jerke U, Mayboroda OA, Vogel F, Bouvet P, et al. Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin. Curr Biol 1999;9:1468-76. (Pubitemid 30023481)
10. Stepanova V, Lebedeva T, Kuo A, Yarovoi S, Tkachuk S, Zaitsev S, et al. Nuclear translocation of urokinase-type plasminogen activator. Blood 2008;112:100-10.
11. Harms G, Kraft R, Grelle G, Volz B, Dernedde J, Tauber R. Identification of nucleolin as a new L-selectin ligand. Biochem J 2001;360:531-8. (Pubitemid 34020257)
12. Larrucea S, González-Rubio C, Cambronero R, Ballou B, Bonay P, López-Granados E, et al. Cellular adhesion mediated by factor J, a complement inhibitor. Evidence for nucleolin involvement. J Biol Chem 1998;273:31718-25. (Pubitemid 29177101)
13. Reyes-Reyes EM, Akiyama SK. Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells. Exp Cell Res 2008;314:2212-23.
14. Turck N, Lefebvre O, Gross I, Gendry P, Kedinger M, Simon-Assmann P, et al. Effect of laminin-1 on intestinal cell differentiation involves inhibition of nuclear nucleolin. J Cell Physiol 2006;206:545-55. (Pubitemid 43062826)
15. Bates PJ, Laber DA, Miller DM, Thomas SD, Trent JO. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp Mol Pathol 2009;86:151-64.
16. Drecoll E, Gaertner FC, Miederer M, Blechert B, Vallon M, Müller JM, et al. Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells. PLoS One 2009;4:e5715.
17. Shi H, Huang Y, Zhou H, Song X, Yuan S, Fu Y, et al. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood 2007;110:2899-906. (Pubitemid 350006943)
18. Destouches D, El Khoury D, Hamma-Kourbali Y, Krust B, Albanese P, Katsoris P, et al. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin. PLoS One 2008;3:e2518.
19. Fogal V, Sugahara KN, Ruoslahti E, Christian S. Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature. Angiogenesis 2009;12:91-100.
20. Otake Y, Sengupta TK, Bandyopadhyay S, Spicer EK, Fernandes DJ. Retinoid-induced apoptosis in HL-60 cells is associated with nucleolin down-regulation and destabilization of Bcl-2 mRNA. Mol Pharmacol 2005;67:319-26. (Pubitemid 40069993)
21. Otake Y, Soundararajan S, Sengupta TK, Kio EA, Smith JC, Pineda-Roman M, et al. Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood 2007;109:3069-75. (Pubitemid 46482108)
22. Takagi M, Absalon MJ, McLure KG, Kastan MB. Regulation of p 53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 2005;123:49-63.
23. Ugrinova I, Monier K, Ivaldi C, Thiry M, Storck S, Mongelard F, et al. Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplication. BMC Mol Biol 2007;8:66.
24. Grinstein E, Shan Y, Karawajew L, Snijders PJ, Meijer CJ, Royer HD, et al. Cell cycle-controlled interaction of nucleolin with the retinoblastoma protein and cancerous cell transformation. J Biol Chem 2006;281:22223-35. (Pubitemid 44181926)
25. Blondet B, Carpentier G, Ferry A, Courty J. Exogenous pleiotrophin applied to lesioned nerve impairs muscle reinnervation. Neurochem Res 2006;31:907-13. (Pubitemid 44134244)
26. Celik I, Sürücü O, Dietz C, Heymach JV, Force J, Höschele I, et al. Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve. Cancer Res 2005; 65:11044-50. (Pubitemid 41713375)
27. Page N, Schall N, Strub JM, Quinternet M, Chaloin O, Decossas M, et al. The spliceosomal phosphopeptide P140 controls the lupus disease by interacting with the HSC70 protein and via a mechanism mediated by gammadelta T cells. PLoS One 2009;4:e5273.
28. Majno G, Joris IApoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146:3-15.
29. Sengupta TK, Bandyopadhyay S, Fernandes DJ, Spicer EK. Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization. J Biol Chem 2004;279:10855-63. (Pubitemid 38401575)
30. Soundararajan S, Chen W, Spicer EK, Courtenay-Luck N, Fernandes DJ. The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res 2008;68:2358-65. (Pubitemid 351521810)
31. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-85. (Pubitemid 28015876)
32. Dhanabal M, Ramchandran R, Waterman MJ, Lu H, Knebelmann B, Segal M, et al. Endostatin induces endothelial cell apoptosis. J Biol Chem 1999;274:11721-6.
33. Ling Y, Lu N, Gao Y, Chen Y, Wang S, Yang Y, et al. Endostar induces apoptotic effects in HUVECs through activation of caspase-3 and decrease of Bcl-2. Anticancer Res 2009;29:411-7.
34. Inder KL, Lau C, Loo D, Chaudhary N, Goodall A, Martin S, et al. Nucleophosmin and nucleolin regulate K-Ras plasma membrane interactions and MAPK signal transduction. J Biol Chem 2009;284:28410-9.
35. Qi W, Shakalya K, Stejskal A, Goldman A, Beeck S, Cooke L, et al. NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells. Oncogene 2008;27:4210-20. (Pubitemid 351969907)
36. Feuerstein N, Chan PK, Mond JJ. Identification of numatrin, the nuclear matrix protein associated with induction of mitogenesis, as the nucleolar protein B23. Implication for the role of the nucleolus in early transduction of mitogenic signals. J Biol Chem 1988;263:10608-12.
37. Chan HJ, Weng JJ, Yung BY. Nucleophosmin/B23-binding peptide inhibits tumor growth and up-regulates transcriptional activity of p53. Biochem Biophys Res Commun 2005;333:396-403. (Pubitemid 40848304)